Publikationsdatum:
2003-09-27
Beschreibung:
Tumor necrosis factor (TNF) is a key regulator of inflammatory responses and has been implicated in many pathological conditions. We used structure-based design to engineer variant TNF proteins that rapidly form heterotrimers with native TNF to give complexes that neither bind to nor stimulate signaling through TNF receptors. Thus, TNF is inactivated by sequestration. Dominant-negative TNFs represent a possible approach to anti-inflammatory biotherapeutics, and experiments in animal models show that the strategy can attenuate TNF-mediated pathology. Similar rational design could be used to engineer inhibitors of additional TNF superfamily cytokines as well as other multimeric ligands.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Steed, Paul M -- Tansey, Malu G -- Zalevsky, Jonathan -- Zhukovsky, Eugene A -- Desjarlais, John R -- Szymkowski, David E -- Abbott, Christina -- Carmichael, David -- Chan, Cheryl -- Cherry, Lisa -- Cheung, Peter -- Chirino, Arthur J -- Chung, Hyo H -- Doberstein, Stephen K -- Eivazi, Araz -- Filikov, Anton V -- Gao, Sarah X -- Hubert, Rene S -- Hwang, Marian -- Hyun, Linus -- Kashi, Sandhya -- Kim, Alice -- Kim, Esther -- Kung, James -- Martinez, Sabrina P -- Muchhal, Umesh S -- Nguyen, Duc-Hanh T -- O'Brien, Christopher -- O'Keefe, Donald -- Singer, Karen -- Vafa, Omid -- Vielmetter, Jost -- Yoder, Sean C -- Dahiyat, Bassil I -- New York, N.Y. -- Science. 2003 Sep 26;301(5641):1895-8.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Xencor, 111 West Lemon Avenue, Monrovia, CA 91016, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/14512626" target="_blank"〉PubMed〈/a〉
Schlagwort(e):
Amino Acid Substitution
;
Animals
;
Antigens, CD/metabolism
;
Apoptosis
;
Arthritis, Experimental/drug therapy
;
Biopolymers
;
Caspases/metabolism
;
Cell Line
;
Cell Nucleus/metabolism
;
Computer Simulation
;
Disease Progression
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Galactosamine/pharmacology
;
HeLa Cells
;
Humans
;
Liver/drug effects
;
NF-kappa B/metabolism
;
Point Mutation
;
*Protein Engineering
;
Rats
;
Receptors, Tumor Necrosis Factor/metabolism
;
Receptors, Tumor Necrosis Factor, Type I
;
Receptors, Tumor Necrosis Factor, Type II
;
*Signal Transduction
;
Transcription Factor RelA
;
Transcription, Genetic
;
Tumor Necrosis Factor-alpha/*antagonists &
;
inhibitors/genetics/metabolism/*pharmacology
Print ISSN:
0036-8075
Digitale ISSN:
1095-9203
Thema:
Biologie
,
Chemie und Pharmazie
,
Informatik
,
Medizin
,
Allgemeine Naturwissenschaft
,
Physik
Permalink
